Hepatocyte-specific loss of PPARγ protects mice from NASH, and increases the therapeutic effects of rosiglitazone in the liver.

出版年份 2021 全文链接

标题

作者

关键词

Rosiglitazone, Methionine Metabolism, Metabolomics, NASH Reversion, AAV8-TBG-Cre

出版物

Cellular and Molecular Gastroenterology and Hepatology

Volume -, Issue -, Pages -

出版商

Elsevier BV

发表日期

2021-01-15

DOI

10.1016/j.jcmgh.2021.01.003

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More